Oud-Heverlee, Belgium

Anne-Marie V Lambeir

This inventor holds 1 USPTO granted patent. Top assignee: Corvas International, Inc.. Active years: 1996.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Anne-Marie V Lambeir. Retrieved from https://idiyas.com/inventor/anne-marie-v-lambeir

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 2.0

ph-index = 1

Forward Citations = 9(Granted Patents)


Company Filing History:


Years Active: 1996

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Inventor Spotlight: Anne-Marie V Lambeir

Introduction

Anne-Marie V Lambeir is a notable inventor based in Oud-Heverlee, Belgium. With a focus on innovations in the pharmaceutical field, she has made significant contributions to advancements in blood coagulation treatment.

Latest Patents

Anne-Marie is credited with one patent, which is titled "Ecotin as a factor Xa, XIa, and XIIa inhibitor - Pharmaceutical composition containing Ecotin in a therapeutically effective amount for inhibition of blood coagulation." This patent highlights her work in developing effective therapeutic interventions for blood coagulation disorders.

Career Highlights

Currently, Anne-Marie is employed at Corvas International, Inc., where she applies her expertise to enhance pharmaceutical developments. Her role involves collaborating on groundbreaking projects that aim to innovate and improve patient healthcare outcomes.

Collaborations

Anne-Marie collaborates with her coworker, Marc Jozef Lauwereys, engaging in joint efforts that further the research and development of new therapeutic solutions, particularly in the realm of anticoagulant therapy.

Conclusion

In summary, Anne-Marie V Lambeir stands out as an accomplished inventor dedicated to improving healthcare through her innovative research. Her contributions in the pharmaceutical industry, especially concerning blood coagulation, illustrate the impactful nature of her work.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…